Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test

Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients

(2011) Maria Benevolo et al.   CANCER CAUSES & CONTROL

Feasibility Study of a Human Papillomavirus E6 Oncoprotein Test for Diagnosis of Cervical Precancer and Cancer

(2010) Johannes Schweizer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Performance of the PreTect HPV-Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer

(2010) S. Ratnam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing

(2010) Sveinung Wergeland Sørbye et al.   PLoS One

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

(2009) Paolo Giorgi Rossi et al.   BMC PUBLIC HEALTH

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate

(2009) Marc Arbyn et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Performance of Human Papillomavirus DNA and mRNA Testing Strategies for Women with and without Cervical Neoplasia

(2009) A. Trope et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

(2009) Janel Dockter et al.   JOURNAL OF CLINICAL VIROLOGY

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ® HPV assay

(2009) Philippe Halfon et al.   JOURNAL OF CLINICAL VIROLOGY

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears

(2008) A. Szarewski et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human Papillomavirus mRNA and p16 Detection as Biomarkers for the Improved Diagnosis of Cervical Neoplasia

(2008) K. Cuschieri et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma

(2008) A Kathrine Lie et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

(2008) G. Ronco et al.   JNCI-Journal of the National Cancer Institute

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

(2008) Margaret RE McCredie et al.   LANCET ONCOLOGY

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

(2008) Jack Cuzick et al.   VACCINE